cDNA accession Links to the sequence |
Tissue most 5' clones in red |
Match mRNA |
From bp to bp in mRNA |
From bp to bp in accs. |
Clone encodes complete protein (with AA variation) |
Features | Anomalies detected by AceView |
Accession match over (% length) |
Base differences relative to genome (% identity) |
M96620 | thymus | .q | 210 to 531 | 23 to 344 | 322/344 (93 %) | 6 diff (98.3 %id) | |||
L25183 | .c | 1490 to 1721 | 247 to 17 | 231/248 (93 %) | 0 diff (100 %id) | ||||
Z47295 | .c | 1807 to 2086 | 1 to 281 | 281/281 (100 %) | 7 diff (97.6 %id) | ||||
AB209578 | Spleen | .n | 1 to 4539 | 1 to 4528 | exact | tiling clone, | 4528/4528 (100 %) | 2 diff (100.0 %id) | |
AV708308 | adrenal gland | .k | 1 to 601 | 1 to 601 | exact | tiling clone, | 601/602 (99 %) | 10 diff (98.4 %id) | |
AW976525 | .m | 1 to 514 | 515 to 1 | Submitted on the opposite strand | 515/517 (99 %) | 18 diff (96.6 %id) | |||
BC031300 | Colon, adenocarcinoma | .a | 1 to 1634 | 1 to 1634 | exact | tiling clone, available from MGC, AAA | 1634/1634 (100 %) | 0 diff (100 %id) | |
BC072012 | Ovary, teratocarcinoma | .c | 28 to 1287 | 1 to 1260 | exact | available from MGC, AAA | 1260/1260 (100 %) | 0 diff (100 %id) | |
BE835511 | prostate_normal | .c | 1362 to 1482 | 1 to 121 | 121/135 (89 %) | 1 diff (99.3 %id) | |||
BF889369 | testis_normal | .h | 1 to 215 | 1 to 215 | tiling clone, | 215/215 (100 %) | 3 diff (98.7 %id) | ||
BF945736 | nervous_normal | .c | 1668 to 2074 | 60 to 466 | 407/466 (87 %) | 6 diff (98.8 %id) | |||
BF946507 | nervous_normal | .g | 1047 to 1410 | 1 to 364 | tiling clone, | 364/364 (100 %) | 0 diff (100 %id) | ||
BI042428 | ovary | .c | 356 to 601 | 1 to 246 | 246/246 (100 %) | 2 diff (99.2 %id) | |||
BI042441 | ovary | .c | 358 to 601 | 1 to 244 | 244/244 (100 %) | 1 diff (99.6 %id) | |||
BI792358 | Pancreas, Purified pancreatic islet | .c | 2020 to 2229 | 216 to 7 | 210/216 (97 %) | 0 diff (100 %id) | |||
BM309980 | insulinoma, Pancreas | .c | 1102 to 1432 | 7 to 337 | 331/337 (98 %) | 0 diff (100 %id) | |||
BM310260 | insulinoma, Pancreas | .c | 1102 to 1431 | 330 to 1 | 330/335 (98 %) | 0 diff (100 %id) | |||
BX094326 | ovarian tumor, ovary | .o-u | 1037 to 1619 | 1 to 583 | tiling clone, AAA | 583/583 (100 %) | 0 diff (100 %id) | ||
F09738 | brain, total brain | .g | 587 to 765 | 1 to 179 | Submitted on the opposite strand | 179/179 (100 %) | 1 diff (99.5 %id) | ||
F12100 | brain, total brain | .g | 2614 to 2944 | 331 to 1 | tiling clone, | Submitted on the opposite strand | 331/331 (100 %) | 1 diff (99.7 %id) | |
CD619459 | .c | 220 to 447 | 1 to 228 | 228/228 (100 %) | 5 diff (97.9 %id) | ||||
CD619460 | .c | 220 to 447 | 227 to 1 | 227/227 (100 %) | 4 diff (98.3 %id) | ||||
CN287912 | embryonic stem cells, cell lines H1, H7, andH9 | .c | 954 to 1521 | 570 to 1 | Submitted on the opposite strand | 570/570 (100 %) | 4 diff (99.3 %id) | ||
CN287913 | embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells | .c | 46 to 601 | 1 to 556 | 556/556 (100 %) | 0 diff (100 %id) | |||
CN287914 | embryonic stem cells, cell lines H1, H7, andH9 | .c | 1986 to 2253 | 294 to 27 | tiling clone, | Submitted on the opposite strand | 268/294 (91 %) | 0 diff (100 %id) | |
CN287915 | embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells | .c | 147 to 629 | 7 to 489 | 483/489 (98 %) | 6 diff (98.8 %id) | |||
CN304231 | embryonic stem cells, DMSO-treated H9 cellline | .p | 1 to 672 | 1 to 673 | tiling clone, | 673/673 (100 %) | 7 diff (99.0 %id) | ||
AL045339 | testis | .g | 1835 to 2144 | 310 to 1 | tiling clone, | Submitted on the opposite strand | 310/311 (99 %) | 1 diff (99.7 %id) | |
EC487398 | Prostate | .c | 604 to 677 | 78 to 6 | 73/78 (93 %) | 0 diff (100 %id) | |||
EL735305 | mixed | .a | 200 to 1042 | 1 to 843 | 843/843 (100 %) | 0 diff (100 %id) | |||
CD676200 | eye, lens | .d | 663 to 1256 | 613 to 20 | AAA | Submitted on the opposite strand | 594/594 (100 %) | 1 diff (99.9 %id) | |
DB443267 | testis | .f | 149 to 589 | 1 to 443 | tiling clone, | 443/443 (100 %) | 22 diff (95.1 %id) | ||
DB528954 | hippocampus | .c | 827 to 1287 | 1 to 458 | Submitted on the opposite strand | 458/458 (100 %) | 12 diff (97.4 %id) | ||
DB533617 | hippocampus | .c | 1823 to 2226 | 1 to 408 | Submitted on the opposite strand | 408/409 (99 %) | 20 diff (95.2 %id) | ||
DB477236 | hippocampus | .f | 1 to 501 | 1 to 507 | A121X Q122S P123A G124X A125G ... | tiling clone, | 507/509 (99 %) | 13 diff (97.5 %id) | |
DB545879 | hippocampus | .b | 761 to 1214 | 1 to 454 | Submitted on the opposite strand | 454/454 (100 %) | 0 diff (100 %id) | ||
DB489451 | hypothalamus | .c | 850 to 1316 | 9 to 474 | 466/474 (98 %) | 6 diff (98.8 %id) | |||
DB558973 | hypothalamus | .c | 1788 to 2227 | 1 to 441 | Submitted on the opposite strand | 441/441 (100 %) | 8 diff (98.2 %id) | ||
DB503400 | hypothalamus | .c | 850 to 1313 | 9 to 473 | 465/473 (98 %) | 6 diff (98.8 %id) | |||
AV729582 | hypothalamus | .k | 1 to 451 | 1 to 451 | exact | 451/452 (99 %) | 1 diff (99.8 %id) | ||
AV728525 | hypothalamus | .k | 1 to 653 | 1 to 653 | exact | tiling clone, | 653/742 (88 %) | 11 diff (98.6 %id) | |
DR980052 | placenta | .c | 1062 to 1286 | 1 to 224 | AAA | Submitted on the opposite strand | 224/224 (100 %) | 6 diff (97.4 %id) | |
T64779 | whole brain | .c | 1003 to 1246 | 236 to 1 | Submitted on the opposite strand | 236/236 (100 %) | 11 diff (95.4 %id) | ||
T72532 | whole brain | .g | 621 to 866 | 1 to 246 | Submitted on the opposite strand | 246/252 (97 %) | 5 diff (98.1 %id) | ||
N22789 | nose, olfactory epithelium | .g | 583 to 1038 | 1 to 456 | Submitted on the opposite strand | 456/458 (99 %) | 5 diff (99.0 %id) | ||
N22796 | nose, olfactory epithelium | .g | 583 to 1040 | 1 to 458 | Submitted on the opposite strand | 458/459 (99 %) | 4 diff (99.2 %id) | ||
N74967 | lung | .o-u | 120 to 250 | 1 to 131 | tiling clone, | Submitted on the opposite strand | 131/131 (100 %) | 3 diff (97.8 %id) | |
W05665 | lung | .o-u | 133 to 284 | 151 to 1 | Submitted on the opposite strand | 151/151 (100 %) | 1 diff (99.4 %id) | ||
N91605 | lung | .c | 200 to 580 | 1 to 375 | Submitted on the opposite strand | 375/465 (80 %) | 11 diff (97.7 %id) | ||
W19196 | lung | .c | 870 to 1294 | 425 to 1 | Submitted on the opposite strand | 425/425 (100 %) | 9 diff (97.9 %id) | ||
N93365 | lung | .g | 1 to 327 | 1 to 347 | tiling clone, | Submitted on the opposite strand | 347/347 (100 %) | 20 diff (94.3 %id) | |
W25383 | lung | .c | 1989 to 2233 | 247 to 2 | Submitted on the opposite strand | 246/247 (99 %) | 0 diff (100 %id) | ||
AA022689 | heart | .c | 1919 to 2227 | 314 to 1 | fully sequenced, | 314/314 (100 %) | 1 diff (99.7 %id) | ||
AA022808 | heart | .c | 1693 to 1949 | 1 to 261 | fully sequenced, | 261/261 (100 %) | 3 diff (98.9 %id) | ||
AA157444 | Pancreas | .c | 140 to 534 | 1 to 396 | 369/396 (93 %) | 14 diff (96.5 %id) | |||
AA157882 | Pancreas | .c | 850 to 1256 | 406 to 1 | 406/422 (96 %) | 2 diff (99.6 %id) | |||
AA194054 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .c | 1292 to 1920 | 1 to 629 | 629/631 (99 %) | 10 diff (98.5 %id) | |||
AA496497 | ovarian tumor, ovary | .m | 43 to 266 | 1 to 224 | fully sequenced, | 224/224 (100 %) | 0 diff (100 %id) | ||
AA496622 | ovarian tumor, ovary | .m | 236 to 514 | 279 to 1 | fully sequenced, | 279/279 (100 %) | 0 diff (100 %id) | ||
AA449186 | .o-u | 534 to 776 | 1 to 242 | 242/242 (100 %) | 4 diff (98.4 %id) | ||||
AA449187 | .o-u | 1639 to 2015 | 375 to 4 | tiling clone, | 372/375 (99 %) | 0 diff (100 %id) | |||
AA447767 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .c | 2015 to 2233 | 219 to 1 | 219/219 (100 %) | 0 diff (100 %id) | |||
AA453698 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .c | 1292 to 1673 | 1 to 382 | 382/382 (100 %) | 3 diff (99.3 %id) | |||
AA532771 | colon | .c | 915 to 1286 | 376 to 4 | 373/376 (99 %) | 0 diff (100 %id) | |||
AA534728 | colon | .a | 192 to 776 | 1 to 580 | Submitted on the opposite strand | 580/580 (100 %) | 14 diff (97.6 %id) | ||
AA563653 | colon | .c | 850 to 1286 | 437 to 1 | 437/439 (99 %) | 1 diff (99.8 %id) | |||
AA542916 | normal prostate, Prostate | .c | 796 to 1286 | 497 to 7 | 491/498 (98 %) | 4 diff (99.2 %id) | |||
AA542934 | normal prostate, Prostate | .c | 795 to 1286 | 496 to 7 | 490/501 (97 %) | 2 diff (99.7 %id) | |||
AA773219 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .l | 1 to 569 | 1 to 557 | E51D L52W D53M A54Q E55R ... | tiling clone, | 557/673 (82 %) | 27 diff (96.0 %id) | |
AA744249 | germinal center B cell | .m | 51 to 266 | 217 to 1 | 217/217 (100 %) | 1 diff (99.6 %id) | |||
AA858031 | Kidney | .c | 285 to 474 | 27 to 214 | Submitted on the opposite strand | 188/214 (87 %) | 7 diff (96.8 %id) | ||
AA834120 | Kidney, kidney tumor | .c | 818 to 1256 | 439 to 1 | 439/439 (100 %) | 5 diff (98.9 %id) | |||
AI147081 | pooled | .o-u | 1858 to 2017 | 159 to 2 | 158/159 (99 %) | 0 diff (100 %id) | |||
AA926833 | pooled | .c | 285 to 602 | 26 to 338 | Submitted on the opposite strand | 313/338 (92 %) | 13 diff (96.2 %id) | ||
AA970674 | pooled | .c | 200 to 475 | 1 to 274 | Submitted on the opposite strand | 274/274 (100 %) | 2 diff (99.3 %id) | ||
AA999875 | Kidney | .o-u | 1856 to 2017 | 161 to 2 | 160/161 (99 %) | 0 diff (100 %id) | |||
AI028786 | .c | 218 to 636 | 1 to 419 | Submitted on the opposite strand | 419/419 (100 %) | 2 diff (99.6 %id) | |||
AI091559 | pooled | .c | 200 to 718 | 1 to 519 | Submitted on the opposite strand | 519/519 (100 %) | 1 diff (99.9 %id) | ||
AI128854 | senescent fibroblast | .c | 827 to 901 | 76 to 2 | 75/76 (98 %) | 0 diff (100 %id) | |||
AI052038 | parathyroid gland, parathyroid tumor | .m | 421 to 845 | 425 to 1 | R67H | tiling clone, | 425/425 (100 %) | 1 diff (99.8 %id) | |
AI081454 | senescent fibroblast | .c | 218 to 687 | 1 to 470 | Submitted on the opposite strand | 470/470 (100 %) | 0 diff (100 %id) | ||
AI126422 | .c | 1844 to 2234 | 394 to 4 | 391/394 (99 %) | 0 diff (100 %id) | ||||
AI223397 | .c | 866 to 1286 | 432 to 12 | AAA | 421/424 (99 %) | 1 diff (99.8 %id) | |||
AI241393 | liver and spleen | .c | 1848 to 2233 | 385 to 1 | 385/385 (100 %) | 1 diff (99.8 %id) | |||
AI244158 | Kidney | .c | 200 to 670 | 1 to 466 | Submitted on the opposite strand | 465/468 (99 %) | 11 diff (97.7 %id) | ||
AI290561 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .p | 456 to 859 | 402 to 1 | tiling clone, | 402/402 (100 %) | 1 diff (99.8 %id) | ||
AI290637 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .p | 319 to 833 | 516 to 1 | exact | tiling clone, | 516/516 (100 %) | 4 diff (99.3 %id) | |
AI265997 | placenta | .c | 848 to 1286 | 442 to 6 | 437/445 (98 %) | 0 diff (100 %id) | |||
AI301036 | carcinoid, lung | .c | 200 to 626 | 1 to 427 | Submitted on the opposite strand | 427/427 (100 %) | 0 diff (100 %id) | ||
AI282432 | Kidney, renal cell tumor | .c | 225 to 523 | 1 to 299 | Submitted on the opposite strand | 299/299 (100 %) | 0 diff (100 %id) | ||
AI306918 | breast, breast carcinoma in situ | .c | 2098 to 2233 | 11 to 146 | AAA | Submitted on the opposite strand | 136/146 (93 %) | 6 diff (95.9 %id) | |
AI275297 | breast, breast carcinoma in situ | .c | 2098 to 2227 | 11 to 140 | AAA | Submitted on the opposite strand | 130/140 (92 %) | 6 diff (95.8 %id) | |
AI307091 | borderline ovarian carcinoma, ovary | .c | 2078 to 2234 | 11 to 167 | AAA | Submitted on the opposite strand | 157/167 (94 %) | 6 diff (96.5 %id) | |
AI249859 | borderline ovarian carcinoma, ovary | .c | 2078 to 2220 | 4 to 160 | AAA | Submitted on the opposite strand | 157/160 (98 %) | 5 diff (96.9 %id) | |
AI250434 | borderline ovarian carcinoma, ovary | .c | 2098 to 2227 | 11 to 140 | AAA | Submitted on the opposite strand | 130/140 (92 %) | 6 diff (95.8 %id) | |
AI493841 | Kidney | .c | 939 to 1286 | 372 to 25 | AAA | 348/348 (100 %) | 7 diff (98.0 %id) | ||
AI493784 | uterus | .c | 869 to 1286 | 418 to 1 | 418/418 (100 %) | 2 diff (99.6 %id) | |||
AI310777 | bronchioalveolar carcinoma, lung | .c | 2078 to 2220 | 4 to 160 | AAA | Submitted on the opposite strand | 157/160 (98 %) | 5 diff (96.9 %id) | |
AI307943 | adenocarcinoma, breast | .c | 2078 to 2220 | 4 to 160 | AAA | Submitted on the opposite strand | 157/160 (98 %) | 5 diff (96.9 %id) | |
AI307832 | adenocarcinoma, breast | .c | 2078 to 2220 | 5 to 161 | AAA | Submitted on the opposite strand | 157/161 (97 %) | 4 diff (97.6 %id) | |
AI309796 | adenocarcinoma, breast | .c | 2078 to 2225 | 11 to 158 | AAA | Submitted on the opposite strand | 148/158 (93 %) | 6 diff (96.3 %id) | |
AI340679 | adenocarcinoma, breast | .c | 2078 to 2220 | 4 to 160 | AAA | Submitted on the opposite strand | 157/160 (98 %) | 4 diff (97.5 %id) | |
AI340759 | adenocarcinoma, breast | .c | 2098 to 2225 | 11 to 138 | AAA | Submitted on the opposite strand | 128/138 (92 %) | 6 diff (95.7 %id) | |
AI349065 | adenocarcinoma, breast | .c | 2078 to 2225 | 11 to 158 | AAA | Submitted on the opposite strand | 148/158 (93 %) | 6 diff (96.3 %id) | |
AI344999 | adenocarcinoma, breast | .c | 2078 to 2220 | 4 to 160 | AAA | Submitted on the opposite strand | 157/160 (98 %) | 4 diff (97.5 %id) | |
AI349905 | brain, oligodendroglioma | .c | 2078 to 2220 | 4 to 160 | AAA | Submitted on the opposite strand | 157/160 (98 %) | 5 diff (96.9 %id) | |
AI350038 | brain, oligodendroglioma | .c | 2078 to 2220 | 4 to 160 | AAA | Submitted on the opposite strand | 157/160 (98 %) | 4 diff (97.5 %id) | |
AI580575 | brain, oligodendroglioma | .c | 2078 to 2220 | 4 to 160 | AAA | Submitted on the opposite strand | 157/160 (98 %) | 5 diff (96.9 %id) | |
AI580622 | brain, oligodendroglioma | .c | 2078 to 2220 | 4 to 160 | AAA | Submitted on the opposite strand | 157/160 (98 %) | 4 diff (97.5 %id) | |
AI580615 | brain, oligodendroglioma | .c | 2078 to 2220 | 4 to 160 | AAA | Submitted on the opposite strand | 157/160 (98 %) | 5 diff (96.9 %id) | |
AI378577 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .c | 1747 to 2233 | 488 to 2 | 487/488 (99 %) | 0 diff (100 %id) | |||
AI539305 | pooled | .c | 218 to 1131 | 1 to 911 | Submitted on the opposite strand | 911/1024 (88 %) | 39 diff (96.2 %id) | ||
AI423069 | brain, glioblastoma (pooled) | .c | 200 to 704 | 1 to 505 | Submitted on the opposite strand | 505/505 (100 %) | 0 diff (100 %id) | ||
AI391609 | brain, glioblastoma (pooled) | .c | 218 to 624 | 1 to 407 | Submitted on the opposite strand | 407/407 (100 %) | 0 diff (100 %id) | ||
AI391472 | B-cell, chronic lymphotic leukemia | .g | 291 to 680 | 399 to 8 | tiling clone, | 392/399 (98 %) | 8 diff (98.0 %id) | ||
AI435708 | adenocarcinoma, breast | .c | 2078 to 2220 | 4 to 160 | AAA | Submitted on the opposite strand | 157/160 (98 %) | 4 diff (97.5 %id) | |
AI432252 | adenocarcinoma, breast | .c | 2078 to 2220 | 4 to 160 | AAA | Submitted on the opposite strand | 157/160 (98 %) | 4 diff (97.5 %id) | |
AI432881 | adenocarcinoma, breast | .c | 2078 to 2225 | 11 to 158 | AAA | Submitted on the opposite strand | 148/158 (93 %) | 6 diff (96.3 %id) | |
AI431536 | adenocarcinoma, breast | .c | 2078 to 2220 | 4 to 160 | AAA | Submitted on the opposite strand | 157/160 (98 %) | 5 diff (96.9 %id) | |
AI492683 | adenocarcinoma, breast | .c | 2078 to 2220 | 15 to 171 | AAA | Submitted on the opposite strand | 157/171 (91 %) | 4 diff (97.7 %id) | |
AI492773 | adenocarcinoma, breast | .c | 2078 to 2220 | 4 to 160 | AAA | Submitted on the opposite strand | 157/160 (98 %) | 5 diff (96.9 %id) | |
AI492803 | adenocarcinoma, breast | .c | 2078 to 2220 | 4 to 160 | AAA | Submitted on the opposite strand | 157/160 (98 %) | 4 diff (97.5 %id) | |
AI435652 | adenocarcinoma, breast | .c | 2078 to 2220 | 4 to 160 | AAA | Submitted on the opposite strand | 157/160 (98 %) | 4 diff (97.5 %id) | |
AI435678 | adenocarcinoma, breast | .c | 2078 to 2220 | 4 to 160 | AAA | Submitted on the opposite strand | 157/160 (98 %) | 4 diff (97.5 %id) | |
AI473076 | adenocarcinoma, breast | .c | 2078 to 2225 | 11 to 158 | AAA | Submitted on the opposite strand | 148/158 (93 %) | 6 diff (96.3 %id) | |
AI479761 | anaplastic oligodendroglioma, brain | .c | 1775 to 2233 | 464 to 6 | 459/464 (98 %) | 0 diff (100 %id) | |||
AI598246 | anaplastic oligodendroglioma, brain | .c | 200 to 668 | 1 to 469 | Submitted on the opposite strand | 469/469 (100 %) | 0 diff (100 %id) | ||
AI565660 | anaplastic oligodendroglioma, brain | .c | 238 to 635 | 1 to 399 | Submitted on the opposite strand | 399/399 (100 %) | 2 diff (99.5 %id) | ||
AI583254 | bone marrow, CD34+, CD38- from normal bone marrow donor | .c | 2078 to 2225 | 11 to 158 | AAA | Submitted on the opposite strand | 148/158 (93 %) | 6 diff (96.3 %id) | |
AI634892 | adenocarcinoma, Pancreas | .c | 2072 to 2181 | 111 to 1 | 111/111 (100 %) | 4 diff (96.4 %id) | |||
AI688081 | pooled | .c | 757 to 1286 | 543 to 11 | AAA | 533/534 (99 %) | 6 diff (98.9 %id) | ||
AI744074 | Prostate | .c | 961 to 1285 | 339 to 15 | AAA | 325/325 (100 %) | 0 diff (100 %id) | ||
AI829704 | pooled | .c | 218 to 771 | 1 to 554 | Submitted on the opposite strand | 554/555 (99 %) | 4 diff (99.3 %id) | ||
AI673404 | colon, colonic mucosa from 5 ulcerative colitispatients | .c | 850 to 1286 | 446 to 9 | 438/460 (95 %) | 0 diff (100 %id) | |||
AI660954 | colon, colonic mucosa from 5 ulcerative colitispatients | .c | 200 to 909 | 1 to 710 | Submitted on the opposite strand | 710/711 (99 %) | 12 diff (98.4 %id) | ||
AI740775 | pooled | .m | 421 to 837 | 417 to 1 | R67H | 417/417 (100 %) | 1 diff (99.8 %id) | ||
AI817734 | anaplastic oligodendroglioma, brain | .a | 240 to 760 | 1 to 521 | Submitted on the opposite strand | 521/521 (100 %) | 1 diff (99.9 %id) | ||
AI826200 | normal prostate, Prostate | .d | 598 to 1255 | 662 to 2 | 658/662 (99 %) | 21 diff (96.9 %id) | |||
AI857530 | anaplastic oligodendroglioma, brain | .c | 1775 to 2229 | 458 to 4 | 455/458 (99 %) | 0 diff (100 %id) | |||
AI927267 | normal prostate, Prostate | .a | 211 to 773 | 1 to 563 | Submitted on the opposite strand | 563/563 (100 %) | 1 diff (99.9 %id) | ||
AI937536 | anaplastic oligodendroglioma, brain | .c | 1778 to 2229 | 456 to 4 | 453/456 (99 %) | 0 diff (100 %id) | |||
AW001482 | colon, colonic mucosa from 3 patients with Crohn'sdisease | .d | 639 to 1255 | 634 to 18 | AAA | 617/628 (98 %) | 26 diff (95.9 %id) | ||
AW001489 | colon, colonic mucosa from 3 patients with Crohn'sdisease | .d | 642 to 1255 | 630 to 18 | AAA | 613/616 (99 %) | 34 diff (94.5 %id) | ||
AI991050 | colon, colonic mucosa from 3 patients with Crohn'sdisease | .d | 172 to 876 | 1 to 704 | Submitted on the opposite strand | 704/707 (99 %) | 11 diff (98.5 %id) | ||
AW024989 | Kidney | .c | 1803 to 2227 | 425 to 1 | 425/425 (100 %) | 2 diff (99.6 %id) | |||
AW026205 | brain, glioblastoma (pooled) | .c | 1669 to 2227 | 559 to 1 | 559/559 (100 %) | 2 diff (99.7 %id) | |||
AW027277 | thymus, pooled | .g | 584 to 1143 | 1 to 560 | tiling clone, | Submitted on the opposite strand | 560/560 (100 %) | 5 diff (99.2 %id) | |
AW027715 | thymus, pooled | .c | 200 to 836 | 1 to 634 | Submitted on the opposite strand | 634/636 (99 %) | 7 diff (98.9 %id) | ||
AW028269 | thymus, pooled | .c | 200 to 756 | 1 to 557 | Submitted on the opposite strand | 557/561 (99 %) | 3 diff (99.5 %id) | ||
AW243961 | connective tissue, five pooled sarcomas, including myxoidliposarcoma, solitary fibrous tumor, malignant fibroushistiocytoma, gastrointestinal stromal tumor, andmesothelioma | .c | 1002 to 1287 | 309 to 24 | AAA | 286/286 (100 %) | 12 diff (95.9 %id) | ||
AW073649 | bone marrow, stem cell 34+/38+ | .c | 2098 to 2226 | 11 to 139 | Submitted on the opposite strand | 129/139 (92 %) | 6 diff (95.7 %id) | ||
AW105156 | pooled | .c | 218 to 793 | 1 to 576 | Submitted on the opposite strand | 576/576 (100 %) | 4 diff (99.4 %id) | ||
AW139051 | .q | 1 to 478 | 1 to 479 | G14S | tiling clone, | Submitted on the opposite strand | 479/479 (100 %) | 2 diff (99.6 %id) | |
AW451598 | .c | 879 to 1286 | 425 to 18 | AAA | 408/409 (99 %) | 0 diff (100 %id) | |||
AW299677 | Kidney | .c | 850 to 1286 | 438 to 2 | 437/443 (98 %) | 0 diff (100 %id) | |||
AW300217 | Kidney | .g | 614 to 1149 | 32 to 567 | Submitted on the opposite strand | 536/567 (94 %) | 6 diff (99.0 %id) | ||
BE018933 | Kidney, renal cell adenocarcinoma | .a | 146 to 793 | 1 to 648 | 648/648 (100 %) | 8 diff (98.8 %id) | |||
AW629095 | pooled | .c | 200 to 823 | 1 to 624 | Submitted on the opposite strand | 624/624 (100 %) | 11 diff (98.3 %id) | ||
BE042264 | borderline ovarian carcinoma, ovary | .c | 2078 to 2222 | 40 to 184 | 145/184 (78 %) | 6 diff (96.8 %id) | |||
BE041802 | borderline ovarian carcinoma, ovary | .c | 2106 to 2233 | 1 to 128 | 128/143 (89 %) | 1 diff (99.4 %id) | |||
BE042305 | borderline ovarian carcinoma, ovary | .c | 2099 to 2229 | 1 to 131 | 131/145 (90 %) | 2 diff (98.7 %id) | |||
AW769616 | 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney | .c | 1023 to 1286 | 265 to 1 | 265/265 (100 %) | 1 diff (99.7 %id) | |||
BF515726 | .o-u | 1706 to 2018 | 313 to 1 | tiling clone, | 313/313 (100 %) | 1 diff (99.7 %id) | |||
BF507869 | .c | 943 to 1286 | 361 to 18 | AAA | 344/344 (100 %) | 8 diff (97.7 %id) | |||
BF508619 | .c | 871 to 1287 | 434 to 18 | AAA | 417/427 (97 %) | 3 diff (99.3 %id) | |||
CF142495 | lymph | .g | 1165 to 1652 | 494 to 7 | tiling clone, | Submitted on the opposite strand | 488/494 (98 %) | 0 diff (100 %id) | |
CF143722 | lymph | .g | 1288 to 1652 | 370 to 7 | tiling clone, | Submitted on the opposite strand | 364/370 (98 %) | 0 diff (100 %id) | |
BE672853 | Prostate | .b | 811 to 1214 | 404 to 1 | 404/404 (100 %) | 8 diff (98.1 %id) | |||
BF431084 | pooled | .m | 515 to 863 | 349 to 1 | tiling clone, | 349/349 (100 %) | 1 diff (99.8 %id) | ||
BE676616 | B-cell, chronic lymphotic leukemia | .c | 218 to 848 | 1 to 630 | Submitted on the opposite strand | 630/630 (100 %) | 4 diff (99.4 %id) | ||
BE856252 | brain, glioblastoma (pooled) | .d | 231 to 901 | 1 to 670 | Submitted on the opposite strand | 670/670 (100 %) | 3 diff (99.6 %id) | ||
BE855827 | brain, glioblastoma (pooled) | .i | 1 to 280 | 1 to 280 | C19I | tiling clone, | Submitted on the opposite strand | 280/280 (100 %) | 5 diff (98.3 %id) |
BF940623 | fibrotheoma, ovary | .c | 211 to 610 | 1 to 400 | Submitted on the opposite strand | 400/400 (100 %) | 17 diff (95.8 %id) | ||
BF111687 | pooled | .c | 1803 to 2233 | 437 to 7 | 431/437 (98 %) | 0 diff (100 %id) | |||
BE272868 | Kidney, renal cell adenocarcinoma | .c | 173 to 486 | 1 to 314 | 314/314 (100 %) | 2 diff (99.4 %id) | |||
BF448627 | fibrotheoma, ovary | .d | 658 to 1036 | 81 to 459 | Submitted on the opposite strand | 379/459 (82 %) | 9 diff (98.1 %id) | ||
BE393702 | endometrium, adenocarcinoma cell line, uterus | .d | 533 to 1019 | 1 to 487 | 487/490 (99 %) | 4 diff (99.2 %id) | |||
BG423898 | Kidney, renal cell adenocarcinoma | .c | 153 to 395 | 1 to 241 | 241/241 (100 %) | 3 diff (98.8 %id) | |||
BG422857 | Kidney, renal cell adenocarcinoma | .d | 125 to 921 | 1 to 789 | tiling clone, | 789/1095 (72 %) | 24 diff (97.9 %id) | ||
BG674157 | skin | .d | 279 to 991 | 1 to 718 | 718/1075 (66 %) | 16 diff (98.6 %id) | |||
BG703207 | brain, hippocampus | .c | 141 to 768 | 1 to 625 | 625/625 (100 %) | 6 diff (99.1 %id) | |||
BG824263 | adenocarcinoma cell line, colon | .c | 9 to 605 | 1 to 596 | 596/596 (100 %) | 9 diff (98.5 %id) | |||
BG912017 | anaplastic oligodendroglioma with 1p/19qloss, brain | .g | 1856 to 2049 | 193 to 1 | Submitted on the opposite strand | 193/193 (100 %) | 1 diff (99.5 %id) | ||
BI223170 | cervical carcinoma cell line, cervix | .c | 942 to 1508 | 570 to 2 | Submitted on the opposite strand | 569/768 (74 %) | 0 diff (100 %id) | ||
BI758588 | brain | .g | 1238 to 1759 | 27 to 548 | tiling clone, | 522/727 (71 %) | 10 diff (98.7 %id) | ||
BI907305 | leukocyte | .h | 313 to 797 | 1 to 484 | tiling clone, | 484/484 (100 %) | 3 diff (99.4 %id) | ||
BI835095 | pooled pancreas and spleen | .c | 1009 to 1765 | 1 to 757 | 757/757 (100 %) | 3 diff (99.7 %id) | |||
CK905256 | insulinoma, Pancreas | .c | 1102 to 1432 | 7 to 337 | 331/337 (98 %) | 3 diff (99.2 %id) | |||
BM021098 | Islets of Langerhans, Pancreas | .c | 2181 to 2229 | 50 to 2 | fully sequenced, | 49/50 (98 %) | 0 diff (100 %id) | ||
BM021344 | Islets of Langerhans, Pancreas | .c | 2151 to 2229 | 1 to 79 | fully sequenced, | 79/79 (100 %) | 1 diff (98.8 %id) | ||
BM023111 | Islets of Langerhans, Pancreas | .c | 2189 to 2230 | 42 to 1 | fully sequenced, | 42/42 (100 %) | 1 diff (97.7 %id) | ||
BM023369 | Islets of Langerhans, Pancreas | .c | 2156 to 2226 | 1 to 71 | fully sequenced, | 71/71 (100 %) | 0 diff (100 %id) | ||
BM547786 | brain, hippocampus | .c | 200 to 1064 | 1 to 871 | L246P A255P | 871/1090 (79 %) | 26 diff (97.7 %id) | ||
BM805547 | brain, hippocampus | .c | 1814 to 2227 | 15 to 427 | AAA | 413/427 (96 %) | 6 diff (98.6 %id) | ||
BU071367 | insulinoma, Pancreas | .d | 789 to 1243 | 455 to 1 | fully sequenced, | 455/455 (100 %) | 1 diff (99.8 %id) | ||
BU071600 | insulinoma, Pancreas | .d | 459 to 850 | 1 to 392 | fully sequenced, | 392/392 (100 %) | 4 diff (99.0 %id) | ||
BU154532 | melanotic melanoma, skin | .c | 1012 to 1869 | 893 to 11 | Submitted on the opposite strand | 883/893 (98 %) | 0 diff (100 %id) | ||
BQ718265 | sympathetic trunk | .h | 50 to 686 | 1 to 637 | tiling clone, | 637/919 (69 %) | 14 diff (98.5 %id) | ||
BU856020 | ovary, teratocarcinoma, cell line | .c | 27 to 509 | 17 to 498 | 482/990 (48 %) | 29 diff (97.1 %id) | |||
CA489339 | .g | 1906 to 2714 | 1 to 817 | tiling clone, | 817/898 (90 %) | 21 diff (97.7 %id) | |||
CD245566 | White Matter | .j | 1 to 509 | 1 to 514 | T79P L80P E81G P82S V83L ... | tiling clone, | 514/741 (69 %) | 8 diff (99.0 %id) | |
CD243394 | testis | .c | 446 to 1164 | 19 to 746 | 728/946 (76 %) | 25 diff (97.4 %id) | |||
CD516796 | White Matter | .o-u | 477 to 1265 | 1 to 802 | 802/940 (85 %) | 30 diff (96.9 %id) | |||
CD516126 | White Matter | .o-u | 477 to 1317 | 1 to 856 | tiling clone, | 856/929 (92 %) | 33 diff (96.5 %id) | ||
TI_57218700 | .g | 1238 to 1759 | 27 to 548 | 522/727 (71 %) | 10 diff (98.7 %id) | ||||
TI_57232713 | .h | 313 to 1099 | 28 to 824 | R9C K48S L49Y C50A C51A ... | tiling clone, | 797/949 (83 %) | 23 diff (97.6 %id) | ||
TI_57166268 | .c | 1000 to 1765 | 53 to 818 | 766/818 (93 %) | 8 diff (99.1 %id) | ||||
AJ003363 | .m | 70 to 467 | 1 to 398 | 398/416 (95 %) | 4 diff (99.1 %id) | ||||
AJ003365 | .q | 161 to 545 | 10 to 394 | 385/398 (96 %) | 3 diff (99.3 %id) | ||||
AJ003360 | .c | 1393 to 1748 | 9 to 364 | 356/366 (97 %) | 8 diff (97.9 %id) | ||||
AJ003364 | .q | 175 to 551 | 1 to 377 | tiling clone, | 377/377 (100 %) | 6 diff (98.5 %id) | |||
AJ003362 | .o-u | 1 to 468 | 474 to 9 | tiling clone, | 466/474 (98 %) | 0 diff (100 %id) | |||
AJ003361 | .o-u | 169 to 562 | 394 to 1 | tiling clone, | 394/394 (100 %) | 3 diff (99.3 %id) | |||
NM_004928.2 | .c | 1 to 2233 | 1 to 2233 | exact | RefSeq, AAA | 2233/2233 (100 %) | 0 diff (100 %id) | ||
DB322949 | .m | 1 to 580 | 1 to 580 | tiling clone, | Submitted on the opposite strand | 580/591 (98 %) | 1 diff (99.9 %id) | ||
CV573742 | cornea, eye | .c | 700 to 1283 | 602 to 19 | AAA | Submitted on the opposite strand | 584/584 (100 %) | 1 diff (99.9 %id) | |
CD723229 | eye, lacrimal gland | .c | 465 to 1058 | 1 to 594 | 594/594 (100 %) | 1 diff (99.9 %id) | |||
CD723245 | eye, lacrimal gland | .c | 465 to 1054 | 1 to 590 | 590/590 (100 %) | 1 diff (99.9 %id) | |||
CR977888 | T-Lymphocytes | .h | 17 to 452 | 1 to 435 | 435/435 (100 %) | 1 diff (99.8 %id) | |||
BM764262 | lymph node, stomach | .c | 1 to 505 | 1 to 506 | 506/506 (100 %) | 1 diff (99.9 %id) | |||
BM761336 | lymph node, stomach | .c | 1 to 569 | 1 to 569 | tiling clone, | 569/569 (100 %) | 0 diff (100 %id) | ||
BM844026 | lymph node, stomach | .c | 1 to 531 | 1 to 533 | 533/533 (100 %) | 2 diff (99.7 %id) | |||
BM842703 | lymph node, stomach | .c | 1 to 505 | 1 to 506 | 506/506 (100 %) | 3 diff (99.5 %id) | |||
BM842437 | lymph node, stomach | .c | 1 to 406 | 1 to 406 | 406/406 (100 %) | 3 diff (99.3 %id) | |||
TI_1948218043 | .a | 199 to 674 | 131 to 606 | fully sequenced, AAA | 476/606 (78 %) | 6 diff (99.1 %id) | |||
TI_1948218044 | .a | 644 to 1329 | 807 to 122 | fully sequenced, | 686/807 (85 %) | 1 diff (99.9 %id) | |||
TI_1948218211 | .a | 199 to 674 | 132 to 607 | fully sequenced, | 476/607 (78 %) | 6 diff (99.1 %id) | |||
TI_1948218212 | .a | 644 to 1329 | 807 to 123 | fully sequenced, | 685/807 (84 %) | 0 diff (100 %id) | |||
TI_1948218383 | .a | 199 to 989 | 138 to 933 | fully sequenced, | 796/933 (85 %) | 12 diff (98.8 %id) | |||
TI_1948218384 | .a | 959 to 1329 | 480 to 108 | fully sequenced, | 373/480 (77 %) | 0 diff (100 %id) | |||
TI_1948218549 | .a | 199 to 1085 | 137 to 1029 | 893/1355 (65 %) | 51 diff (96.3 %id) | ||||
DN996966 | breast cancer, Mammary gland (cancer tissue) | .c | 2 to 529 | 1 to 528 | 528/528 (100 %) | 4 diff (99.3 %id) | |||
BM193593 | leukopheresis | .c | 563 to 828 | 266 to 1 | 266/266 (100 %) | 0 diff (100 %id) | |||
BM145270 | leukopheresis | .a | 596 to 816 | 220 to 1 | 220/226 (97 %) | 10 diff (95.6 %id) | |||
BM145290 | leukopheresis | .a | 567 to 816 | 250 to 1 | 250/257 (97 %) | 55 diff (78.6 %id) | |||
TI_149302008 | .c | 754 to 1293 | 637 to 97 | AAA | 541/793 (68 %) | 11 diff (98.7 %id) | |||
TI_154088900 | .c | 921 to 1240 | 49 to 368 | Submitted on the opposite strand | 320/641 (49 %) | 3 diff (99.6 %id) | |||
TI_154173484 | .g | 1059 to 1652 | 691 to 94 | Submitted on the opposite strand | 598/1163 (51 %) | 19 diff (98.4 %id) | |||
TI_154175261 | .g | 1184 to 1651 | 541 to 74 | Submitted on the opposite strand | 468/469 (99 %) | 16 diff (96.6 %id) | |||
U84569 | teratocarcinoma | .d | 1 to 1249 | 1 to 1248 | R106A | tiling clone, AAA | 1248/1248 (100 %) | 6 diff (99.6 %id) | |
U84570 | placenta | .e | 1 to 1183 | 1 to 1182 | R65A | tiling clone, | 1182/1182 (100 %) | 5 diff (99.6 %id) | |
CB850937 | lung, Primary Lung Cystic Fibrosis EpithelialCells | .c | 879 to 1293 | 435 to 19 | AAA | 417/417 (100 %) | 4 diff (99.1 %id) | ||
CA314162 | Human Lung Epithelial cells, lung | .c | 620 to 1286 | 685 to 19 | AAA | 667/669 (99 %) | 5 diff (99.3 %id) | ||
CB243932 | Human Lung Epithelial cells, lung | .a | 946 to 1634 | 707 to 19 | AAA | 689/689 (100 %) | 1 diff (99.9 %id) | ||
BM665515 | eye, human retina | .c | 1559 to 2233 | 692 to 19 | AAA | 674/675 (99 %) | 1 diff (99.9 %id) | ||
BU733416 | eye, optic nerve | .c | 562 to 1286 | 743 to 19 | AAA | 725/725 (100 %) | 1 diff (99.9 %id) | ||
BM709571 | eye, optic nerve | .b | 602 to 963 | 1 to 362 | tiling clone, fully sequenced, | 362/362 (100 %) | 0 diff (100 %id) | ||
BU733583 | eye, optic nerve | .b | 902 to 1220 | 337 to 19 | tiling clone, fully sequenced, AAA | 319/319 (100 %) | 0 diff (100 %id) | ||
BM680482 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .d | 695 to 1255 | 580 to 19 | fully sequenced, AAA | 562/562 (100 %) | 1 diff (99.9 %id) | ||
BM718028 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .d | 598 to 756 | 1 to 159 | fully sequenced, | 159/159 (100 %) | 0 diff (100 %id) | ||
BQ189620 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .d | 598 to 1229 | 1 to 632 | fully sequenced, | 632/632 (100 %) | 0 diff (100 %id) | ||
CK300457 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .d | 758 to 1255 | 518 to 19 | fully sequenced, AAA | 500/500 (100 %) | 2 diff (99.6 %id) | ||
CA425554 | Bone, Subchondral Bone | .c | 1579 to 2227 | 665 to 19 | AAA | 647/647 (100 %) | 2 diff (99.7 %id) | ||
CA427089 | Bone, Subchondral Bone | .d | 663 to 1255 | 611 to 19 | AAA | 593/593 (100 %) | 0 diff (100 %id) | ||
BU616329 | Bone, Subchondral Bone | .e | 1036 to 1739 | 723 to 19 | tiling clone, AAA | 705/705 (100 %) | 2 diff (99.8 %id) | ||
CA444985 | lung, Metastatic Chondrosarcoma | .c | 735 to 1285 | 570 to 19 | AAA | 552/552 (100 %) | 1 diff (99.9 %id) | ||
TI_151733953 | .d | 597 to 1255 | 747 to 87 | tiling clone, AAA | 661/971 (68 %) | 2 diff (99.8 %id) | |||
Y11392 | lung, pancreas | .c | 140 to 2233 | 1 to 2093 | exact | tiling clone, AAA | 2093/2093 (100 %) | 2 diff (100.0 %id) | |
Z93322 | lung | .c | 202 to 2233 | 1 to 2032 | T150I | 2032/2032 (100 %) | 2 diff (100.0 %id) | ||
AA199736. matches multiple genes | .d | 533 to 1019 | 1 to 487 | This clone was ignored, also hits gene fargo, smerjey | 487/490 (99 %) | 4 diff (99.2 %id) | |||
AA199736. matches multiple genes | .c | 153 to 395 | 1 to 241 | This clone was ignored, also hits gene fargo, smerjey | 241/241 (100 %) | 3 diff (98.8 %id) | |||
AA199736. matches multiple genes | .c | 153 to 395 | 1 to 241 | This clone was ignored, also hits gene fargo, smerjey | 241/241 (100 %) | 3 diff (98.8 %id) | |||
AA199782. matches multiple genes | .d | 125 to 921 | 1 to 789 | tiling clone, | This clone was ignored, also hits gene fargo, smerjey | 789/1095 (72 %) | 24 diff (97.9 %id) | ||
AA199782. matches multiple genes | .d | 125 to 921 | 1 to 789 | tiling clone, | This clone was ignored, also hits gene fargo, smerjey | 789/1095 (72 %) | 24 diff (97.9 %id) | ||
AA199782. matches multiple genes | .d | 279 to 991 | 1 to 718 | This clone was ignored, also hits gene fargo, smerjey | 718/1075 (66 %) | 16 diff (98.6 %id) | |||
AA635706 | normal prostate, Prostate | .c | 141 to 768 | 1 to 625 | This clone was ignored | 625/625 (100 %) | 6 diff (99.1 %id) | ||
AI669573 | Prostate | .c | 141 to 768 | 1 to 625 | This clone was ignored | 625/625 (100 %) | 6 diff (99.1 %id) | ||
AI870362 | anaplastic oligodendroglioma, brain | .c | 9 to 605 | 1 to 596 | Suspected internal deletion, this clone was ignored | 596/596 (100 %) | 9 diff (98.5 %id) | ||
BE551009 | carcinoid, lung | .c | 9 to 605 | 1 to 596 | Submitted on the opposite strand, submitted on the opposite strand | 596/596 (100 %) | 9 diff (98.5 %id) | ||
BE856078 | Prostate | .g | 1856 to 2049 | 193 to 1 | AAA | This clone was ignored | 193/193 (100 %) | 1 diff (99.5 %id) | |
BQ960822 | sciatic nerve | .g | 1856 to 2049 | 193 to 1 | Submitted on the opposite strand | 193/193 (100 %) | 1 diff (99.5 %id) | ||
BI223170 | cervical carcinoma cell line, cervix | .c | 942 to 1508 | 570 to 2 | Submitted on the opposite strand | 569/768 (74 %) | 0 diff (100 %id) | ||
BI223170 | cervical carcinoma cell line, cervix | .c | 942 to 1508 | 570 to 2 | Submitted on the opposite strand | 569/768 (74 %) | 0 diff (100 %id) | ||
BI758588 | brain | .g | 1238 to 1759 | 27 to 548 | tiling clone, | 522/727 (71 %) | 10 diff (98.7 %id) | ||
BI907305 | leukocyte | .h | 313 to 797 | 1 to 484 | tiling clone, | 484/484 (100 %) | 3 diff (99.4 %id) | ||
BI835095 | pooled pancreas and spleen | .c | 1009 to 1765 | 1 to 757 | 757/757 (100 %) | 3 diff (99.7 %id) | |||
CK905256 | insulinoma, Pancreas | .c | 1102 to 1432 | 7 to 337 | 331/337 (98 %) | 3 diff (99.2 %id) | |||
CK905256 | insulinoma, Pancreas | .c | 1102 to 1432 | 7 to 337 | 331/337 (98 %) | 3 diff (99.2 %id) | |||
BM021098 | Islets of Langerhans, Pancreas | .c | 2181 to 2229 | 50 to 2 | fully sequenced, | 49/50 (98 %) | 0 diff (100 %id) | ||
BM021098 | Islets of Langerhans, Pancreas | .c | 2181 to 2229 | 50 to 2 | fully sequenced, | 49/50 (98 %) | 0 diff (100 %id) | ||
BM021344 | Islets of Langerhans, Pancreas | .c | 2151 to 2229 | 1 to 79 | fully sequenced, | 79/79 (100 %) | 1 diff (98.8 %id) | ||
BM021344 | Islets of Langerhans, Pancreas | .c | 2151 to 2229 | 1 to 79 | fully sequenced, | 79/79 (100 %) | 1 diff (98.8 %id) | ||
BM023111 | Islets of Langerhans, Pancreas | .c | 2189 to 2230 | 42 to 1 | fully sequenced, | 42/42 (100 %) | 1 diff (97.7 %id) | ||
BM023111 | Islets of Langerhans, Pancreas | .c | 2189 to 2230 | 42 to 1 | fully sequenced, | 42/42 (100 %) | 1 diff (97.7 %id) | ||
BM023369 | Islets of Langerhans, Pancreas | .c | 2156 to 2226 | 1 to 71 | fully sequenced, | 71/71 (100 %) | 0 diff (100 %id) | ||
BM023369 | Islets of Langerhans, Pancreas | .c | 2156 to 2226 | 1 to 71 | fully sequenced, | 71/71 (100 %) | 0 diff (100 %id) | ||
BM547786 | brain, hippocampus | .c | 200 to 1064 | 1 to 871 | L246P A255P | 871/1090 (79 %) | 26 diff (97.7 %id) | ||
BM547786 | brain, hippocampus | .c | 200 to 1064 | 1 to 871 | L246P A255P | 871/1090 (79 %) | 26 diff (97.7 %id) | ||
BM805547 | brain, hippocampus | .c | 1814 to 2227 | 15 to 427 | AAA | 413/427 (96 %) | 6 diff (98.6 %id) | ||
BM805547 | brain, hippocampus | .c | 1814 to 2227 | 15 to 427 | AAA | 413/427 (96 %) | 6 diff (98.6 %id) | ||
BU071367 | insulinoma, Pancreas | .d | 789 to 1243 | 455 to 1 | fully sequenced, | 455/455 (100 %) | 1 diff (99.8 %id) | ||
BU071367 | insulinoma, Pancreas | .d | 789 to 1243 | 455 to 1 | fully sequenced, | 455/455 (100 %) | 1 diff (99.8 %id) | ||
BU071600 | insulinoma, Pancreas | .d | 459 to 850 | 1 to 392 | fully sequenced, | 392/392 (100 %) | 4 diff (99.0 %id) | ||
BU071600 | insulinoma, Pancreas | .d | 459 to 850 | 1 to 392 | fully sequenced, | 392/392 (100 %) | 4 diff (99.0 %id) | ||
BU154532 | melanotic melanoma, skin | .c | 1012 to 1869 | 893 to 11 | Submitted on the opposite strand | 883/893 (98 %) | 0 diff (100 %id) | ||
BU154532 | melanotic melanoma, skin | .c | 1012 to 1869 | 893 to 11 | Submitted on the opposite strand | 883/893 (98 %) | 0 diff (100 %id) | ||
BQ718265 | sympathetic trunk | .h | 50 to 686 | 1 to 637 | tiling clone, | 637/919 (69 %) | 14 diff (98.5 %id) | ||
BU856020 | ovary, teratocarcinoma, cell line | .c | 27 to 509 | 17 to 498 | 482/990 (48 %) | 29 diff (97.1 %id) | |||
BU856020 | ovary, teratocarcinoma, cell line | .c | 27 to 509 | 17 to 498 | 482/990 (48 %) | 29 diff (97.1 %id) | |||
CA489339 | .g | 1906 to 2714 | 1 to 817 | tiling clone, | 817/898 (90 %) | 21 diff (97.7 %id) | |||
CD245566 | White Matter | .j | 1 to 509 | 1 to 514 | T79P L80P E81G P82S V83L ... | tiling clone, | 514/741 (69 %) | 8 diff (99.0 %id) | |
CD243394 | testis | .c | 446 to 1164 | 19 to 746 | 728/946 (76 %) | 25 diff (97.4 %id) | |||
CD516796 | White Matter | .o-u | 477 to 1265 | 1 to 802 | 802/940 (85 %) | 30 diff (96.9 %id) | |||
CD516126 | White Matter | .o-u | 477 to 1317 | 1 to 856 | tiling clone, | 856/929 (92 %) | 33 diff (96.5 %id) | ||
TI_57218700 | .g | 1238 to 1759 | 27 to 548 | 522/727 (71 %) | 10 diff (98.7 %id) | ||||
TI_57232713 | .h | 313 to 1099 | 28 to 824 | R9C K48S L49Y C50A C51A ... | tiling clone, | 797/949 (83 %) | 23 diff (97.6 %id) | ||
TI_57166268 | .c | 1000 to 1765 | 53 to 818 | 766/818 (93 %) | 8 diff (99.1 %id) | ||||
AJ003363 | .m | 70 to 467 | 1 to 398 | 398/416 (95 %) | 4 diff (99.1 %id) | ||||
AJ003365 | .q | 161 to 545 | 10 to 394 | 385/398 (96 %) | 3 diff (99.3 %id) | ||||
AJ003360 | .c | 1393 to 1748 | 9 to 364 | 356/366 (97 %) | 8 diff (97.9 %id) | ||||
AJ003364 | .q | 175 to 551 | 1 to 377 | tiling clone, | 377/377 (100 %) | 6 diff (98.5 %id) | |||
AJ003362 | .o-u | 1 to 468 | 474 to 9 | tiling clone, | 466/474 (98 %) | 0 diff (100 %id) | |||
AJ003361 | .o-u | 169 to 562 | 394 to 1 | tiling clone, | 394/394 (100 %) | 3 diff (99.3 %id) | |||
NM_004928.2 | .c | 1 to 2233 | 1 to 2233 | exact | RefSeq, AAA | 2233/2233 (100 %) | 0 diff (100 %id) | ||
DB322949 | .m | 1 to 580 | 1 to 580 | tiling clone, | Submitted on the opposite strand | 580/591 (98 %) | 1 diff (99.9 %id) | ||
CV573742 | cornea, eye | .c | 700 to 1283 | 602 to 19 | AAA | Submitted on the opposite strand | 584/584 (100 %) | 1 diff (99.9 %id) | |
CV573742 | cornea, eye | .c | 700 to 1283 | 602 to 19 | AAA | Submitted on the opposite strand | 584/584 (100 %) | 1 diff (99.9 %id) | |
CD723229 | eye, lacrimal gland | .c | 465 to 1058 | 1 to 594 | 594/594 (100 %) | 1 diff (99.9 %id) | |||
CD723229 | eye, lacrimal gland | .c | 465 to 1058 | 1 to 594 | 594/594 (100 %) | 1 diff (99.9 %id) | |||
CD723245 | eye, lacrimal gland | .c | 465 to 1054 | 1 to 590 | 590/590 (100 %) | 1 diff (99.9 %id) | |||
CD723245 | eye, lacrimal gland | .c | 465 to 1054 | 1 to 590 | 590/590 (100 %) | 1 diff (99.9 %id) | |||
CR977888 | T-Lymphocytes | .h | 17 to 452 | 1 to 435 | 435/435 (100 %) | 1 diff (99.8 %id) | |||
BM764262 | lymph node, stomach | .c | 1 to 505 | 1 to 506 | 506/506 (100 %) | 1 diff (99.9 %id) | |||
BM764262 | lymph node, stomach | .c | 1 to 505 | 1 to 506 | 506/506 (100 %) | 1 diff (99.9 %id) | |||
BM761336 | lymph node, stomach | .c | 1 to 569 | 1 to 569 | tiling clone, | 569/569 (100 %) | 0 diff (100 %id) | ||
BM761336 | lymph node, stomach | .c | 1 to 569 | 1 to 569 | tiling clone, | 569/569 (100 %) | 0 diff (100 %id) | ||
BM844026 | lymph node, stomach | .c | 1 to 531 | 1 to 533 | 533/533 (100 %) | 2 diff (99.7 %id) | |||
BM844026 | lymph node, stomach | .c | 1 to 531 | 1 to 533 | 533/533 (100 %) | 2 diff (99.7 %id) | |||
BM842703 | lymph node, stomach | .c | 1 to 505 | 1 to 506 | 506/506 (100 %) | 3 diff (99.5 %id) | |||
BM842703 | lymph node, stomach | .c | 1 to 505 | 1 to 506 | 506/506 (100 %) | 3 diff (99.5 %id) | |||
BM842437 | lymph node, stomach | .c | 1 to 406 | 1 to 406 | 406/406 (100 %) | 3 diff (99.3 %id) | |||
BM842437 | lymph node, stomach | .c | 1 to 406 | 1 to 406 | 406/406 (100 %) | 3 diff (99.3 %id) | |||
TI_1948218043 | .a | 199 to 674 | 131 to 606 | fully sequenced, AAA | 476/606 (78 %) | 6 diff (99.1 %id) | |||
TI_1948218044 | .a | 644 to 1329 | 807 to 122 | fully sequenced, | 686/807 (85 %) | 1 diff (99.9 %id) | |||
TI_1948218211 | .a | 199 to 674 | 132 to 607 | fully sequenced, | 476/607 (78 %) | 6 diff (99.1 %id) | |||
TI_1948218212 | .a | 644 to 1329 | 807 to 123 | fully sequenced, | 685/807 (84 %) | 0 diff (100 %id) | |||
TI_1948218383 | .a | 199 to 989 | 138 to 933 | fully sequenced, | 796/933 (85 %) | 12 diff (98.8 %id) | |||
TI_1948218384 | .a | 959 to 1329 | 480 to 108 | fully sequenced, | 373/480 (77 %) | 0 diff (100 %id) | |||
TI_1948218549 | .a | 199 to 1085 | 137 to 1029 | 893/1355 (65 %) | 51 diff (96.3 %id) | ||||
DN996966 | breast cancer, Mammary gland (cancer tissue) | .c | 2 to 529 | 1 to 528 | 528/528 (100 %) | 4 diff (99.3 %id) | |||
DN996966 | breast cancer, Mammary gland (cancer tissue) | .c | 2 to 529 | 1 to 528 | 528/528 (100 %) | 4 diff (99.3 %id) | |||
BM193593 | leukopheresis | .c | 563 to 828 | 266 to 1 | 266/266 (100 %) | 0 diff (100 %id) | |||
BM145270 | leukopheresis | .a | 596 to 816 | 220 to 1 | 220/226 (97 %) | 10 diff (95.6 %id) | |||
BM145290 | leukopheresis | .a | 567 to 816 | 250 to 1 | 250/257 (97 %) | 55 diff (78.6 %id) | |||
TI_149302008 | .c | 754 to 1293 | 637 to 97 | AAA | 541/793 (68 %) | 11 diff (98.7 %id) | |||
TI_154088900 | .c | 921 to 1240 | 49 to 368 | Submitted on the opposite strand | 320/641 (49 %) | 3 diff (99.6 %id) | |||
TI_154173484 | .g | 1059 to 1652 | 691 to 94 | Submitted on the opposite strand | 598/1163 (51 %) | 19 diff (98.4 %id) | |||
TI_154175261 | .g | 1184 to 1651 | 541 to 74 | Submitted on the opposite strand | 468/469 (99 %) | 16 diff (96.6 %id) | |||
U84569 | teratocarcinoma | .d | 1 to 1249 | 1 to 1248 | R106A | tiling clone, AAA | 1248/1248 (100 %) | 6 diff (99.6 %id) | |
U84570 | placenta | .e | 1 to 1183 | 1 to 1182 | R65A | tiling clone, | 1182/1182 (100 %) | 5 diff (99.6 %id) | |
CB850937 | lung, Primary Lung Cystic Fibrosis EpithelialCells | .c | 879 to 1293 | 435 to 19 | AAA | 417/417 (100 %) | 4 diff (99.1 %id) | ||
CB850937 | lung, Primary Lung Cystic Fibrosis EpithelialCells | .c | 879 to 1293 | 435 to 19 | AAA | 417/417 (100 %) | 4 diff (99.1 %id) | ||
CA314162 | Human Lung Epithelial cells, lung | .c | 620 to 1286 | 685 to 19 | AAA | 667/669 (99 %) | 5 diff (99.3 %id) | ||
CA314162 | Human Lung Epithelial cells, lung | .c | 620 to 1286 | 685 to 19 | AAA | 667/669 (99 %) | 5 diff (99.3 %id) | ||
CB243932 | Human Lung Epithelial cells, lung | .a | 946 to 1634 | 707 to 19 | AAA | 689/689 (100 %) | 1 diff (99.9 %id) | ||
CB243932 | Human Lung Epithelial cells, lung | .a | 946 to 1634 | 707 to 19 | AAA | 689/689 (100 %) | 1 diff (99.9 %id) | ||
BM665515 | eye, human retina | .c | 1559 to 2233 | 692 to 19 | AAA | 674/675 (99 %) | 1 diff (99.9 %id) | ||
BM665515 | eye, human retina | .c | 1559 to 2233 | 692 to 19 | AAA | 674/675 (99 %) | 1 diff (99.9 %id) | ||
BU733416 | eye, optic nerve | .c | 562 to 1286 | 743 to 19 | AAA | 725/725 (100 %) | 1 diff (99.9 %id) | ||
BU733416 | eye, optic nerve | .c | 562 to 1286 | 743 to 19 | AAA | 725/725 (100 %) | 1 diff (99.9 %id) | ||
BM709571 | eye, optic nerve | .b | 602 to 963 | 1 to 362 | tiling clone, fully sequenced, | 362/362 (100 %) | 0 diff (100 %id) | ||
BM709571 | eye, optic nerve | .b | 602 to 963 | 1 to 362 | tiling clone, fully sequenced, | 362/362 (100 %) | 0 diff (100 %id) | ||
BU733583 | eye, optic nerve | .b | 902 to 1220 | 337 to 19 | tiling clone, fully sequenced, AAA | 319/319 (100 %) | 0 diff (100 %id) | ||
BU733583 | eye, optic nerve | .b | 902 to 1220 | 337 to 19 | tiling clone, fully sequenced, AAA | 319/319 (100 %) | 0 diff (100 %id) | ||
BM680482 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .d | 695 to 1255 | 580 to 19 | fully sequenced, AAA | 562/562 (100 %) | 1 diff (99.9 %id) | ||
BM680482 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .d | 695 to 1255 | 580 to 19 | fully sequenced, AAA | 562/562 (100 %) | 1 diff (99.9 %id) | ||
BM718028 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .d | 598 to 756 | 1 to 159 | fully sequenced, | 159/159 (100 %) | 0 diff (100 %id) | ||
BM718028 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .d | 598 to 756 | 1 to 159 | fully sequenced, | 159/159 (100 %) | 0 diff (100 %id) | ||
BQ189620 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .d | 598 to 1229 | 1 to 632 | fully sequenced, | 632/632 (100 %) | 0 diff (100 %id) | ||
BQ189620 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .d | 598 to 1229 | 1 to 632 | fully sequenced, | 632/632 (100 %) | 0 diff (100 %id) | ||
CK300457 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .d | 758 to 1255 | 518 to 19 | fully sequenced, AAA | 500/500 (100 %) | 2 diff (99.6 %id) | ||
CK300457 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .d | 758 to 1255 | 518 to 19 | fully sequenced, AAA | 500/500 (100 %) | 2 diff (99.6 %id) | ||
CA425554 | Bone, Subchondral Bone | .c | 1579 to 2227 | 665 to 19 | AAA | 647/647 (100 %) | 2 diff (99.7 %id) | ||
CA425554 | Bone, Subchondral Bone | .c | 1579 to 2227 | 665 to 19 | AAA | 647/647 (100 %) | 2 diff (99.7 %id) | ||
CA427089 | Bone, Subchondral Bone | .d | 663 to 1255 | 611 to 19 | AAA | 593/593 (100 %) | 0 diff (100 %id) | ||
CA427089 | Bone, Subchondral Bone | .d | 663 to 1255 | 611 to 19 | AAA | 593/593 (100 %) | 0 diff (100 %id) | ||
BU616329 | Bone, Subchondral Bone | .e | 1036 to 1739 | 723 to 19 | tiling clone, AAA | 705/705 (100 %) | 2 diff (99.8 %id) | ||
BU616329 | Bone, Subchondral Bone | .e | 1036 to 1739 | 723 to 19 | tiling clone, AAA | 705/705 (100 %) | 2 diff (99.8 %id) | ||
CA444985 | lung, Metastatic Chondrosarcoma | .c | 735 to 1285 | 570 to 19 | AAA | 552/552 (100 %) | 1 diff (99.9 %id) | ||
CA444985 | lung, Metastatic Chondrosarcoma | .c | 735 to 1285 | 570 to 19 | AAA | 552/552 (100 %) | 1 diff (99.9 %id) | ||
TI_151733953 | .d | 597 to 1255 | 747 to 87 | tiling clone, AAA | 661/971 (68 %) | 2 diff (99.8 %id) | |||
Y11392 | lung, pancreas | .c | 140 to 2233 | 1 to 2093 | exact | tiling clone, AAA | 2093/2093 (100 %) | 2 diff (100.0 %id) | |
Z93322 | lung | .c | 202 to 2233 | 1 to 2032 | T150I | 2032/2032 (100 %) | 2 diff (100.0 %id) |